POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE

<p><strong>Aim. </strong>To evaluate the functional activity of platelets by the optical standard aggregatometry and induced flow cytofluorometry during antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA).</p><p><strong>Material and methods. </...

Full description

Bibliographic Details
Main Authors: O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
Format: Article
Language:English
Published: Столичная издательская компания 2015-09-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/38
_version_ 1797716828427911168
author O. V. Sirotkina
A. B. Laskovets
A. S. Lipunova
L. B. Gaykovaya
S. A. Boldueva
T. V. Vavilova
author_facet O. V. Sirotkina
A. B. Laskovets
A. S. Lipunova
L. B. Gaykovaya
S. A. Boldueva
T. V. Vavilova
author_sort O. V. Sirotkina
collection DOAJ
description <p><strong>Aim. </strong>To evaluate the functional activity of platelets by the optical standard aggregatometry and induced flow cytofluorometry during antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA).</p><p><strong>Material and methods. </strong>The evaluation of platelet function in 30 patients with ischemic heart disease treated with dual antiplatelet therapy (ASA and clopidogrel) was performed by two methods: the standard photometric method with the assessment of degree of light transmission at the maximum point and by the original method of induced flow cytofluorometry with the platelet activity evaluation by changing of glycoprotein (GP) IIb/IIIa receptor level and the expression of P-selectin before and after ADP induction.</p><p><strong>Results. </strong>Increase in platelet functional activity was detected in patients with ASA monotherapy at initial evaluation by both induced flow cytofluorometry and standard photometric method. After one month dual antiplatelet therapy platelet function significantly decreased according to standard photometric method (from 61.4Ѓ}3.6 to 45.9Ѓ}3.7; p&lt;0.05; the induction of 2.5 mM ADP), as well as according to flow cytofluorometry with changing of GP IIb/IIIa receptor level (from 12.2Ѓ}0.8% to 5.2Ѓ}0.8%; p&lt;0.05) and the expression of P-selectin (from 70.5Ѓ}5.9% to 57.4Ѓ}5.9%; p&lt;0.05).</p><p><strong>Conclusion. </strong>The combined use of laboratory methods to assess platelet function (traditional and high-tech) provides cardiologist with additional tool for assessing the effectiveness of antiplatelet therapy in patients with ischemic heart disease.</p>
first_indexed 2024-03-12T08:27:20Z
format Article
id doaj.art-f52b9afaaff64fdea64aede5b117d18a
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-03-12T08:27:20Z
publishDate 2015-09-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-f52b9afaaff64fdea64aede5b117d18a2023-09-02T18:03:46ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-0191313410.1234/1819-6446-2013-1-31-3438POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASEO. V. Sirotkina0A. B. Laskovets1A. S. Lipunova2L. B. Gaykovaya3S. A. Boldueva4T. V. Vavilova5Северо-Западный государственный медицинский университет им. И.И.Мечникова, Санкт-Петербург; Петербургский институт ядерной физики им. Б.П.Константинова, Гатчина, Ленинградская обл.Северо-Западный государственный медицинский университет им. И.И.Мечникова, Санкт-ПетербургСеверо-Западный государственный медицинский университет им. И.И.Мечникова, Санкт-ПетербургСеверо-Западный государственный медицинский университет им. И.И.Мечникова, Санкт-ПетербургСеверо-Западный государственный медицинский университет им. И.И.Мечникова, Санкт-ПетербургСеверо-Западный государственный медицинский университет им. И.И.Мечникова, Санкт-Петербург<p><strong>Aim. </strong>To evaluate the functional activity of platelets by the optical standard aggregatometry and induced flow cytofluorometry during antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA).</p><p><strong>Material and methods. </strong>The evaluation of platelet function in 30 patients with ischemic heart disease treated with dual antiplatelet therapy (ASA and clopidogrel) was performed by two methods: the standard photometric method with the assessment of degree of light transmission at the maximum point and by the original method of induced flow cytofluorometry with the platelet activity evaluation by changing of glycoprotein (GP) IIb/IIIa receptor level and the expression of P-selectin before and after ADP induction.</p><p><strong>Results. </strong>Increase in platelet functional activity was detected in patients with ASA monotherapy at initial evaluation by both induced flow cytofluorometry and standard photometric method. After one month dual antiplatelet therapy platelet function significantly decreased according to standard photometric method (from 61.4Ѓ}3.6 to 45.9Ѓ}3.7; p&lt;0.05; the induction of 2.5 mM ADP), as well as according to flow cytofluorometry with changing of GP IIb/IIIa receptor level (from 12.2Ѓ}0.8% to 5.2Ѓ}0.8%; p&lt;0.05) and the expression of P-selectin (from 70.5Ѓ}5.9% to 57.4Ѓ}5.9%; p&lt;0.05).</p><p><strong>Conclusion. </strong>The combined use of laboratory methods to assess platelet function (traditional and high-tech) provides cardiologist with additional tool for assessing the effectiveness of antiplatelet therapy in patients with ischemic heart disease.</p>http://www.rpcardio.ru/jour/article/view/38клопидогрелантиагрегантная терапияGP IIb/IIIa рецепторыР-селектининдуцированная проточная тромбоцитометрия
spellingShingle O. V. Sirotkina
A. B. Laskovets
A. S. Lipunova
L. B. Gaykovaya
S. A. Boldueva
T. V. Vavilova
POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE
Рациональная фармакотерапия в кардиологии
клопидогрел
антиагрегантная терапия
GP IIb/IIIa рецепторы
Р-селектин
индуцированная проточная тромбоцитометрия
title POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_full POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_fullStr POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_full_unstemmed POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_short POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_sort possibilities of clinical laboratory evaluation of antiplatelet therapy effectiveness in patients with ischemic heart disease
topic клопидогрел
антиагрегантная терапия
GP IIb/IIIa рецепторы
Р-селектин
индуцированная проточная тромбоцитометрия
url http://www.rpcardio.ru/jour/article/view/38
work_keys_str_mv AT ovsirotkina possibilitiesofclinicallaboratoryevaluationofantiplatelettherapyeffectivenessinpatientswithischemicheartdisease
AT ablaskovets possibilitiesofclinicallaboratoryevaluationofantiplatelettherapyeffectivenessinpatientswithischemicheartdisease
AT aslipunova possibilitiesofclinicallaboratoryevaluationofantiplatelettherapyeffectivenessinpatientswithischemicheartdisease
AT lbgaykovaya possibilitiesofclinicallaboratoryevaluationofantiplatelettherapyeffectivenessinpatientswithischemicheartdisease
AT saboldueva possibilitiesofclinicallaboratoryevaluationofantiplatelettherapyeffectivenessinpatientswithischemicheartdisease
AT tvvavilova possibilitiesofclinicallaboratoryevaluationofantiplatelettherapyeffectivenessinpatientswithischemicheartdisease